课题基金 / 基金详情

INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY

INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
研究肺癌致瘤性中的 NAPDH 氧化酶和氧化还原信号传导
批准号:
9283379
负责人:
Jason M. Held
金额:
$34.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30

项目摘要

项目成果

Jason M. Held的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Lung cancer results in the largest number of cancer-related deaths in the United States. Non-small cell lung cancer (NSCLC) patient tumors overexpress NADPH oxidases that produce intracellular hydrogen peroxide (H2O2) and play an important role in lung cancer tumorigenicity. To date, our preliminary results demonstrate that NOX activity is functionally important for NCSLC transformation, escape from anoikis, phosphorylation signaling, and redox regulation of cysteines in several novel intracellular proteins. The fundamental goal of this proposal is to study the molecular details of NOX-dependent redox signaling in lung cancer biology. Aim 1 of the proposal will characterize the functional role of NOX isoforms overexpressed in lung patient tumors in lung cancer tumorigenicity. Aim 2 will examine the regulatory crosstalk between phosphorylation signaling and NOX activity by profiling NOX-dependent kinase activity. Aim 3 will quantitatively map the cysteine targets of NOX- derived H2O2 in NSCLC upon NOX inhibition. Investigating the role of NOX enzymes and redox signaling in lung cancer will shed light on orthogonal control mechanisms regulating cancer cell growth, transformation and evasion of anoikis. There is a strong link between RAS mutations, overexpression of NOX and increased ROS production. Therefore, investigating redox signaling in NSCLC may identify new regulators and therapeutic targets for intervention in lung cancer, especially RAS-driven tumors with no clear therapeutic option.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
  • 批准号:
    10576645
  • 项目类别:
  • 资助金额:
    $18.31万
  • 财政年份:
    2022
  • 负责人:
    Jason M. Held
  • 依托单位:
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging
  • 批准号:
    9751694
  • 项目类别:
  • 资助金额:
    $19.61万
  • 财政年份:
    2018
  • 负责人:
    Jason M. Held
  • 依托单位:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
  • 批准号:
    9175407
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2016
  • 负责人:
    Jason M. Held
  • 依托单位:
The role of p53 redox-modification in cell fate signaling
  • 批准号:
    8569469
  • 项目类别:
  • 资助金额:
    $20.48万
  • 财政年份:
    2013
  • 负责人:
    Jason M. Held
  • 依托单位:
国内基金
海外基金
胃肠安方抑制整合素αvβ6促进胃癌细胞Anoikis防治胃癌转移的机制研究
  • 批准号:
    82305335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    卢艳琳
  • 依托单位:
AMPK通路调控CEMIP诱导自噬对前列腺癌细胞anoikis耐受的影响及机制
  • 批准号:
    81772751
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    邢毅飞
  • 依托单位:
Myxoma 病毒蛋白Serp-1促进肝癌细胞Anoikis的作用及机制研究
  • 批准号:
    81372597
  • 项目类别:
    面上项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2013
  • 负责人:
    陈昊
  • 依托单位:
TrkB/BDNF通路对前列腺癌EMT、anoikis和血管生成的影响及分子机制
  • 批准号:
    81272847
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2012
  • 负责人:
    邢毅飞
  • 依托单位: